Close Menu

A Pretty Nice Pasture

The former president of product development at Genentech, Susan Desmond-Hellmann, will be taking up a chancellor post at the University of California, San Francisco, after the Board of Regents votes on her appointment later this week, reports the WSJ Health Blog. Before joining Genentech, Desmond-Hellman trained at UCSF, then practiced as an oncologist. At Genentech, she oversaw the development of Avastin, Herceptin, and Rituxan.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.